BACKGROUND: We hypothesized that major co-morbidities affect survival and complications after gastric bypass. METHODS: A total of 1465 patients undergoing laparoscopic and open gastric bypass between 1995 and 2002 were studied. Patients with a body mass index >or= 35 kg/m(2) and major co-morbidities (group 1, n = 1045) were compared with patients with a body mass index >or= 40 kg/m(2) with minor/no co-morbidities (group 2, n = 420). RESULTS: Group 1 patients were older (43 versus 36 years, P < 0.001) and had a greater BMI (53 versus 50 kg/m(2), P < 0.001). Early postoperative complications were greater in group 1 than in group 2 and included leaks (4.1% versus 1.2%, P < 0.0032) and wound infections (3.9% versus 1.4%, P < 0.0133). Procedure-related mortality in the series was 1.7%. Mortality was 10-fold greater in group 1 (2.3% versus 0.2%, P < 0.0032). The incidence of small bowel obstruction, incisional hernia, and pulmonary embolism was similar in the two groups. Excess weight loss was significantly greater in group 2 (68% versus 62%, P < 0.001) at 1 year. Resolution of group 1 co-morbidities was great, including hypertension in 62%, diabetes in 75%, venous stasis disease in 96%, and pseudotumor cerebri in 98%. CONCLUSION: Outcomes analysis of obesity surgery requires risk stratification. The very low mortality rates in published studies are likely explained by surgical treatment of low-risk patients with minor co-morbidities, such as those seen in group 2. However, despite the increased perioperative risk, the group 1 patients (with major co-morbidities) demonstrated dramatic resolution of their co-morbid conditions, justifying the decision to go forward with surgery. The data support a radical change in treatment philosophy in which morbidly obese individuals should be offered bariatric surgery before major co-morbid conditions develop as a strategy to decrease the operative risk.
BACKGROUND: We hypothesized that major co-morbidities affect survival and complications after gastric bypass. METHODS: A total of 1465 patients undergoing laparoscopic and open gastric bypass between 1995 and 2002 were studied. Patients with a body mass index >or= 35 kg/m(2) and major co-morbidities (group 1, n = 1045) were compared with patients with a body mass index >or= 40 kg/m(2) with minor/no co-morbidities (group 2, n = 420). RESULTS: Group 1 patients were older (43 versus 36 years, P < 0.001) and had a greater BMI (53 versus 50 kg/m(2), P < 0.001). Early postoperative complications were greater in group 1 than in group 2 and included leaks (4.1% versus 1.2%, P < 0.0032) and wound infections (3.9% versus 1.4%, P < 0.0133). Procedure-related mortality in the series was 1.7%. Mortality was 10-fold greater in group 1 (2.3% versus 0.2%, P < 0.0032). The incidence of small bowel obstruction, incisional hernia, and pulmonary embolism was similar in the two groups. Excess weight loss was significantly greater in group 2 (68% versus 62%, P < 0.001) at 1 year. Resolution of group 1 co-morbidities was great, including hypertension in 62%, diabetes in 75%, venous stasis disease in 96%, and pseudotumor cerebri in 98%. CONCLUSION: Outcomes analysis of obesity surgery requires risk stratification. The very low mortality rates in published studies are likely explained by surgical treatment of low-risk patients with minor co-morbidities, such as those seen in group 2. However, despite the increased perioperative risk, the group 1 patients (with major co-morbidities) demonstrated dramatic resolution of their co-morbid conditions, justifying the decision to go forward with surgery. The data support a radical change in treatment philosophy in which morbidly obese individuals should be offered bariatric surgery before major co-morbid conditions develop as a strategy to decrease the operative risk.
Authors: Noëlle Geubbels; L Maurits de Brauw; Yair I Z Acherman; Arnold W J M van de Laar; Sjoerd C Bruin Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: José Manuel Fort; Ramon Vilallonga; Albert Lecube; Oscar Gonzalez; Enric Caubet; Jordi Mesa; Manel Armengol Journal: Obes Surg Date: 2013-08 Impact factor: 4.129
Authors: Garth H Ballantyne; Scott Belsley; Daniel Stephens; John K Saunders; Amit Trivedi; Douglas R Ewing; Vincent Iannace; Daniel Davis; Rafael F Capella; Annette Wasielewski; S Moran; Hans J Schmidt Journal: Obes Surg Date: 2008-04-03 Impact factor: 4.129
Authors: Gary M Pratt; Chris A Learn; Gail D Hughes; Bobby L Clark; Mike Warthen; Walter Pories Journal: Surg Endosc Date: 2009-01-30 Impact factor: 4.584
Authors: Caroline M Apovian; Sue Cummings; Wendy Anderson; Loren Borud; Kelly Boyer; Kristina Day; Edward Hatchigian; Barbara Hodges; Mary E Patti; Mark Pettus; Frank Perna; Daniel Rooks; Edward Saltzman; June Skoropowski; Michael B Tantillo; Phyllis Thomason Journal: Obesity (Silver Spring) Date: 2009-02-19 Impact factor: 5.002
Authors: Janey S A Pratt; Carine M Lenders; Emily A Dionne; Alison G Hoppin; George L K Hsu; Thomas H Inge; David F Lawlor; Margaret F Marino; Alan F Meyers; Jennifer L Rosenblum; Vivian M Sanchez Journal: Obesity (Silver Spring) Date: 2009-02-19 Impact factor: 5.002
Authors: Guilherme M Campos; Charlotte Rabl; Kathleen Mulligan; Andrew Posselt; Stanley J Rogers; Antonio C Westphalen; Feng Lin; Eric Vittinghoff Journal: Arch Surg Date: 2008-09